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Background: In the Netherlands, most patients with severe mental illness (SMI) receive flexible assertive
community treatment (FACT) provided by multidisciplinary community mental health teams. SMI patients
with comorbid posttraumatic stress disorder (PTSD) are sometimes offered evidence-based trauma-focused
treatment like eye movement desensitization reprocessing or prolonged exposure. There is a large amount of
evidence for the effectiveness of narrative exposure therapy (NET) within various vulnerable patient groups
with repeated interpersonal trauma. Some FACT-teams provide NET for patients with comorbid PTSD,
which is promising, but has not been specifically studied in SMI patients.
Objectives: The primary aim is to evaluate NET in SMI patients with comorbid PTSD associated with repeated
interpersonal trauma to get insight into whether (1) PTSD and dissociative symptoms changes and (2) changes
occur in the present SMI symptoms, care needs, quality of life, global functioning, and care consumption.
The second aim is to gain insight into patients’ experiences with NET and to identify influencing factors on
treatment results.
Methods: This study will have a mixed methods convergent design consisting of quantitative repeated measures
and qualitative semi-structured in-depth interviews based on Grounded Theory. The study population will
include adult SMI outpatients (n25) with comorbid PTSD and receiving NET. The quantitative study
parameters will be existence and severity of PTSD, dissociative, and SMI symptoms; care needs; quality of
life; global functioning; and care consumption. In a longitudinal analysis, outcomes will be analyzed using
mixed models to estimate the difference in means between baseline and repeated measurements. The qualitative
study parameters will be experiences with NET and perceived factors for success or failure. Integration
of quantitative and qualitative results will be focused on interpreting how qualitative results enhance the
understanding of quantitative outcomes.
Discussion: The results of this study will provide more insight into influencing factors for clinical changes in
this population.
Keywords: Physical abuse; sexual abuse; posttraumatic stress disorder; schizophrenia; mood disorder; personality disorder;
flexible assertive community treatment; mixed methods; repeated measures; in-depth interview
Highlights of the article
 Nearly 50% of severely mentally ill (SMI) patients have been exposed to repeated violence and 30% is
suffering from PTSD.
 Narrative exposure therapy (NET) is designed for PTSD related to repeated trauma and proved
effective in refugees and other vulnerable patient groups.
 NET is provided to SMI patients with PTSD and the first clinical outcomes are promising.
 This study will analyze symptom changes after NET in relation to patients’ experiences with this
treatment.
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D
espite the large attention in research for trauma
and posttraumatic stress disorder (PTSD),
the interest in the prevalence and treatment
options for trauma and PTSD in severely mentally ill
(SMI) populations is scarce, albeit growing. Research
results show that documentation of trauma and trauma
symptoms is exceptionally low in medical records of
SMI patients. Improved recognition is needed to provide
adequate treatment and meaningful services to this
vulnerable population (Cusack, Grubaugh, Knapp, & Frueh,
2006; De Bont et al., 2013; Kilcommons & Morrision,
2005; Mueser et al., 1998, 2004). In a recently conducted
review on trauma and PTSD in SMI, the population
weighted mean prevalence rates are, respectively, physical
abuse 47%, sexual abuse 37%, and PTSD 30%. (Mauritz,
Goossens, Draijer, & Van Achterberg, 2013). These
prevalence rates are significantly higher than in the general
population where the prevalence of physical abuse is
21% and sexual abuse is 23% (Briere & Elliott, 2003),
and the lifetime prevalence of PTSD is estimated to be
6.8% among adult Americans (Kessler, Berglund, Demler,
Jin, & Walters, 2005; Kessler, Chiu, Demler, Merikangas,
& Walters, 2005) and 7.4% in de Netherlands (De Vries
& Olff, 2009). Repeated interpersonal trauma such as
physical and sexual abuse may result in PTSD with
dissociative symptoms, which is classified as PTSD, dis-
sociative subtype in DSM-5 (American Psychiatric Asso-
ciation [APA], 2013). Interpersonal trauma and comorbid
PTSD both have a negative influence on the course of the
SMI (Mauritz et al., 2013; Mueser, Goodman, Rosenberg,
& Trumbetta, 2002). Trauma exposure itself is strongly
related to several other psychiatric disorders. Childhood
trauma, for instance, is identified as a causal factor in
the development of psychotic disorders (Read, Van Os,
Morrison, & Ross, 2005). It is also shown that PTSD in
patients with SMI can be treated effectively using the
following treatment options: cognitive restructuring (Lu
et al., 2009; Mueser et al., 2008), prolonged exposure (PE)
(Frueh et al., 2009; Van Minnen, Harned, Zoellner,
& Mills, 2012) or eye movement desensitization reproces-
sing (EMDR) (Van Den Berg & Van Der Gaag, 2012).
In a recently conducted randomized controlled trial, both
PE and EMDR treatment appeared effective, safe, and
feasible in patients with severe psychotic disorders and
comorbid PTSD (Van den Berg et al., 2015).
Narrative exposure therapy (NET) is a relatively new
trauma-focused treatment. It has been shown effective in
vulnerable groups like refugees and other patients with a
history of repeated trauma exposure including patients
with borderline personality disorder (BPD) or major
depression and comorbid PTSD. NET appeared to
be well tolerated in these groups (Gwozdziewycz &
Mehl-Madrona, 2013; Neuner et al., 2008; Pabst et al.,
2014; Robjant & Fazel, 2010; Stenmark, Catani, Neuner,
Elbert, & Holen, 2013). NET is indicated for PTSD as a
result of repeated trauma, usually as a result of inter-
personal violence.
Objectives
The primary aim of this study is to evaluate NET in SMI
patients with comorbid PTSD associated with repeated
interpersonal trauma to get insight into whether (1) the
PTSD and present dissociative symptoms changes and (2)
changes occur in the present SMI symptoms, care needs,
quality of life, global functioning, and care consumption.
The second aim is to gain insight into patients’ experi-
ences with NET and to identify influencing factors on
treatment results in terms of symptom changes, care
needs, and quality of life.
Methods
This study uses a mixed methods convergent design:
a quantitative repeated measures design and qualitative
methods consisting of a Grounded Theory design. The
aim of a mixed methods design is to integrate quantita-
tive and qualitative components to obtain additional
knowledge (Boeije, Slagt, & Van Wesel, 2013; Creswell &
Zhang, 2009). In this study, integration will be focused on
interpreting how qualitative outcomes regarding patients’
experiences with NET enhance the understanding of the
quantitative clinical outcomes.
Study population
The study population consists of adult (aged 2165 years)
SMI patients receiving flexible assertive community
treatment (FACT). SMI is defined as the presence of
schizophrenia-spectrum disorder, mood disorder, or per-
sonality disorder and decreased global functioning,
which is operationalized by a Global Assessment of
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Functioning (GAF)-score B60 during 2 or more years
(Kessler et al., 2003; Mauritz et al., 2013; Ruggeri, Leese,
Thornicroft, Bisoffi & Tansella, 2000). FACT includes
coordinated multidisciplinary treatment (i.e., pharma-
cotherapy, cognitive behavioral therapy, and other rele-
vant evidence-based interventions) and collaborative care
(i.e., case management and nursing care) for patients in a
stable phase. Unstable patients receive intensive asser-
tive outreaching care delivered by more team members
according to the principle of shared caseload (Drukker,
Visser, Sytema, & Van Os, 2013; Van Veldhuizen, 2007).
Patients with a history of repeated interpersonal trauma
(physical and/or sexual abuse) and with comorbid PTSD
are offered NET by trained FACT-team therapists. Parti-
cipants will be recruited from all FACT-teams from 10
community mental health teams at a large mental health
institute in the east Netherlands. Inclusion will start at the
beginning of 2016 and will last to the end of 2017.
Potential participants will obtain oral and written
information about the study from their treating psychiatrist
and the primary investigator. They will be asked to sign an
informed consent form if they are willing to participate.
Inclusion criteria
In order to be eligible to participate in this study, a patient
must meet the following criteria for the existence of
SMI: (1) a diagnosis of schizophrenia (DSM-5 295.90),
or schizoaffective disorder (DSM-5 295.70), bipolar
disorder type I (DSM-5 296.4046 or 296.5056) or
type II (DSM-5 296.89), or major depressive disorder
(DSM-5 296.2026 or 296.3036) (APA, 2013) according
to the Mini-International Neuropsychiatric Interview
(M.I.N.I.-plus) (Sheehan et al., 1998) or personality dis-
order (DSM 5 301.xx) according to the Structured
Clinical Interview for DSM-IV Personality Disorders
SCID-II (First, Spitzer, Gibbon, & Williams, 1995) and
each has a GAF-score (APA, 2000) B60 during ]2 years
according to the chart diagnosis; (2) a trauma history
including repeated physical and/or sexual abuse according
to the Life Events Checklist for DSM-5 (LEC-5)
(Boeschoten, Bakker, Jongedijk, & Olff, 2014a); and (3)
PTSD according to the Clinician-Administered PTSD
Scale for DSM-5 (CAPS-5) (Boeschoten et al., 2014).
Exclusion criteria
A potential patient who meets any of the following
criteria will be excluded from participation in this study:
(1) the provision of other trauma-focused treatment in
the past year, (2) the existence of an antisocial personality
disorder, (3) the existence of a dissociative identity
disorder, and (4) the provision of involuntary treatment
following the Dutch Mental Health Law.
Withdrawal of participants
Participants can leave the study at any time for any
reason if they wish to do so without any consequences.
In case participants do leave the study, a maximum of
five leaving participants will be replaced before the end of
2017. Patients who do not complete their NET will stay in
the study, unless they want to leave the study. Withdrawal
will be monitored and analyzed.
Sample size
We expect to be able to include 25 participants within 2 years.
This number of participants will be sufficient to quantify the
clinical changes as assessed by the diagnostic instruments
used in this population. For qualitative in-depth analysis, the
number of 25 participants will be sufficient and enables
integral analysis by comparing quantitative and qualitative
results within each individual and the whole group.
Treatment with narrative exposure therapy
Schauer, Neuner, and Elbert (2011) describe the proved
effective main elements of NET as follows: (1) an active
chronological reconstruction of the autobiographical
memory, (2) PE to the traumatic memory with full acti-
vation of the emotional fear network through detailed
narration and imagination of the traumatic event, (3)
meaningful linkage and integration of physiological,
sensory, cognitive, and emotional responses to the persons
Table 1. Measurements in scheme
T0 inclusion and before intervention T1 1 month after finalizing intervention T2 7 months follow-up
Demographics Collected via the electronic record
Care consumption Collected via the electronic record
Trauma history LEC-5
PTSD symptoms CAPS-5 CAPS-5 CAPS-5
Dissociative symptoms DES DES DES
SMI diagnosis M.I.N.I.-plus or SCID-II
SMI symptoms HoNOS HoNOS HoNOS
Care needs CAN CAN CAN
Quality of life MANSA MANSA MANSA
Global functioning GAF GAF GAF
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time, space, and life context, (4) cognitive re-evaluation of
behavior and patterns, reinterpretation of the meaning
content through reprocessing of fearful and traumatic
events, with completion and closure, (5) revisiting of posi-
tive life experiences, and (6) regaining of dignity through
satisfaction of the need for acknowledgment through
‘‘testifying’’ (Jongedijk, 2014; Schauer et al., 2011).
The provision of NET is outlined as follows: Session 1:
psycho-education; Session 2: the lifeline which is symbo-
lized by a rope with a coiled end, stones (traumatic
events) and flowers (positive life experiences) in time
sequences; Session 3: start of the narration beginning
at birth and continuing through to the first traumatic
event; Session 4 and subsequent sessions: rereading of
the narrative collected in previous sessions and continu-
ing the narration of subsequent life and traumatic events;
and final session: rereading and signing the whole
document. The average number of the weekly 90-min
sessions varies from 6 to 16 (Jongedijk, 2014; Jongedijk
& Mauritz, 2016; Schauer et al., 2011). NET is provided
by both nurse practitioners and psychologists who are
all thoroughly trained by official qualified and certified
trainers and who receive video supervision by a certified
psychologist or nurse practitioner. The weekly NET
sessions will be arranged and conducted at the regional
mental health care center location.
Data collection
Quantitative measurements
Patients will participate in the study for 10 months.
At pre-treatment (T0), a trained and supervised research
assistant will collect demographic information from the
electronic record and assess baseline measurements of
all variables. These variables include trauma history,
PTSD diagnosis and symptoms, dissociative symptoms,
SMI diagnosis and symptoms, care needs, quality of life
and global functioning. At post-treatment 1 month after
NET (T1) and after 7 months follow-up (T2), clinical
outcomes including PTSD symptoms, dissociative symp-
toms, SMI symptoms, care needs, quality of life, and
global functioning are assessed again (see Table 1).
Care consumption and prescribed psychiatric medica-
tions will be collected via the electronic record. These
data will be analyzed for the following period: 3 months
before T0 up to and including T2.
Demographic information
Demographic variables include gender, age, marital
status, level of completed education, number and dura-
tion of traumatic event types (emotional, physical, and/or
sexual abuse in childhood and/or adulthood), primary
SMI diagnosis, duration of illness, prescribed medication,
and experiences with forced hospitalization and seclu-
sion. These variables are largely collected via the electro-
nic record and based on the inclusion interview outcomes.
Care consumption
Care consumption is defined as the number and time
duration in minutes of contacts with FACT-team members
and prescribed psychiatric medications (type and doses).
Instruments
Life Events Checklist for DSM-5
The LEC is developed concurrently with the CAPS to
facilitate the diagnosis of PTSD and is a measure of
exposure to 17 potentially traumatic events. The LEC is
evaluated in college undergraduates and combat veterans
by Gray, Litz, Hsu, and Lombardo (2004). In this study,
the LEC had temporal stability and convergent validity
and was strongly associated with PTSD symptoms in a
clinical sample. The LEC-5 connects to the CAPS-5 and
has some minimal changes compared with the original
LEC (Weathers et al., 2013b). The LEC-5 will be adminis-
tered after positive screening for repeated trauma exposure
on the Trauma Screening Questionnaire (TSQ) (Brewin
et al., 2002; De Bont et al., 2015) and PTSD on the PTSD
checklist for the DSM-5 (PCL-5) (Boeschoten, Jongedijk,
& Olff, 2014b; Weathers et al., 2013). The Dutch version of
the LEC-5 will be used in this study (Boeschoten et al.,
2014a).
Dissociative Experiences Scale
Dissociative symptoms are measured using the Dissocia-
tive Experiences Scale (DES), which consists of 28 items
and records the severity of dissociative symptoms. The
total score for the DES can range from 0 to 100. A total
score over 40 suggests a dissociative disorder (Bernstein
& Putnam, 1986; Carlson et al., 1993). The Dutch version
of the DES discriminates dissociative disorders from
other psychiatric disorders and appeared as a reliable
and valid instrument (Draijer & Boon, 1993; Ensink &
Van Otterloo, 1989).
Clinician-Administered PTSD Scale for DSM-5
The CAPS is a structured diagnostic interview designed
for PTSD according to DSM-IV (Blake et al., 2005).
The CAPS is considered as the gold standard clinical
interview to establish the diagnosis of PTSD (Weathers,
Keane & Davidson, 2001). The CAPS-5 is based on the
Table 2. The mixed methods convergent design in scheme.
0 1 2 3 4 5 6 7 8 9 10
Months NET Follow-up
Data collection T0 T1 I T2
Quantitative: measurements
Qualitative: semi-structured
interviews
Maria W. Mauritz et al.
4
(page number not for citation purpose)
Citation: European Journal of Psychotraumatology 2016, 7: 32473 - http://dx.doi.org/10.3402/ejpt.v7.32473
original CAPS for DSM-IV but has several important
revisions based on the corresponding DSM-5 criteria for
PTSD. This 30-item structured interview can be used to
make current (past month) and lifetime diagnosis of
PTSD and assess PTSD symptoms over the past week
(Weathers et al., 2013a). The Dutch version of the CAPS-
5 will be used (Boeschoten et al., 2014).
Mini-International Neuropsychiatric Interview
The M.I.N.I.-plus is a short structured diagnostic inter-
view, developed jointly by psychiatrists and clinicians in
the United States and Europe, for DSM-IV and ICD-10
psychiatric disorders. The M.I.N.I.-plus was designed as a
brief structured interview for the major Axis I psychiatric
disorders in DSM-IV and ICD-10. Validation and relia-
bility studies show that the M.I.N.I.-plus has acceptably
high validation and reliability scores and can be adminis-
tered in a short period of time (mean 18.7911.6 min,
median 15 min). It can be used by clinicians after a
brief training session (Sheehan et al., 1998). The Dutch
version of the M.I.N.I.-plus is tested in a selected group of
Dutch psychiatric patients. Based on initial experiences
and results, Van Vliet and De Beurs (2007) conclude that
the good psychometric characteristics of the M.I.N.I.-plus
make it a good choice for research purposes. Because of its
brevity (2030 min), the interview seems to be especially
convenient for diagnosing psychiatric patients in everyday
clinical practice (Van Vliet & De Beurs, 2007).
Structured Clinical Interview for DSM-IV Personality
Disorders
The SCID-II is a clinician-administered semi-structured
interview for diagnosing the Axis II personality disorders
of the DSM-III-R. It was designed to provide a rapid
clinical assessment of personality disorders without the
loss of reliability or validity (First et al., 1995). After the
publication of the DSM-IV in 1994, the SCID-II has been
revised to meet the DSM-IV criteria (SCID-II version 2.0).
Maffei et al. (1997) assessed the interrater reliability and
internal consistency of the SCID-II 2.0 and concluded
that this version of the SCID-II has adequate interrater
and internal consistency reliability. In the Netherlands,
the reliability of the Dutch version of the SCID-II was
further investigated with regard to the testretest interrater
reliability. Testretest interrater reliability for the presence
or absence of any personality disorder was fair to good
and was higher than values found in previous short-
interval testretest studies with the SCID-II for DSM-
III-R (Weertman, Arntz, Dreessen, Velzen, & Vertommen,
2003).
Health of the Nation Outcome Scale
The Health of the Nation Outcome Scale (HoNOS) has
been developed for assessing the effectiveness of mental
health services for patients with SMI. It covers a wide
range of areas and has good criterion and concurrent
validity (Orrell, Yard, Handysides, & Schapira, 1999).
Rees, Richards, and Shapiro (2004) assessed the usefulness
of the HoNOS in measuring change in a community
mental health population and concluded that a change
of 34 points was statistically significant and useful for
tracking clinical improvement. The Dutch translation
of the HoNOS has been studied and provided insight at
both individual and group level into the seriousness of
problems and into occurred changes. It has reasonably
good psychometric qualities, can be administrated in a
short time, is not dependent on psychiatric diagnosis or
language, and is used by both clinicians and patients
(Mulder et al., 2004). The HoNOS is designed for the
heterogeneous SMI population and is suitable to evaluate
possible symptom changes within the individual and also
at group level.
Camberwell Assessment of Needs
The Camberwell Assessment of Need (CAN) is com-
monly used for comprehensive needs assessment in mental
health services. It is a valid, reliable, and usable measuring
instrument to assess the care need of SMI patients
(Phelan et al., 1995). Wennstro¨m, Sorbom, and Wiesel
(2004) concluded after exploratory factor analysis that
the CAN represents three homogeneous dimensions:
functional disability, social loneliness, and emotional
loneliness. The summary scores of items corresponding
to functional disability and social health might be more
reliable and more sensitive to changes over time than the
standard CAN summary scores.
Manchester Short Assessment of quality of life
The MANSA is a short instrument for assessing quality of
life in people with mental illness. This instrument measures
satisfaction of life as a whole and with life domains
(Priebe, Huxley, Knight, & Evans, 1999). The MANSA
was examined with regard to reliability and construct vali-
dity in patients with SMI. Internal consistency was ade-
quate (a0.81). The construct validity of the scale was
satisfactory in this study (Bjo¨rkman & Svensson, 2005).
Global Assessment of Functioning Scale
The GAF Scale measures psychological, social, and
occupational functioning. This scale considers a hypothe-
tical continuum of mental health illness and does not
include impairment in functioning as a result of physical
or environmental limitations. It is used for the DSM-IV
classification (APA, 2000).
Qualitative semi-structured interviews
To investigate participants’ experiences with NET and to
identify possible influencing factors for success or failure
of NET, participants will be interviewed. Sensitizing
concepts are (1) experiences during NET, (2) symptom
changes, (3) care needs, (4) quality of life and daily life
functioning, and (5) influencing factors and meaning.
Narrative exposure therapy for post traumatic stress disorder in SMI
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Based on these concepts, the following topics are derived
and listed: ad 1: therapeutic relationship, lifeline, narra-
tion, exposure, and the treatment effects in daily life; ad 2:
experienced symptoms; ad 3: perceived care needs; ad 4:
perceived quality of life and effects on daily functioning;
and ad 5: experienced success or failure and significance
for meaningfulness in daily life (see Supplementary file).
The interviews will be held 3 months after finalizing
NET (see Table 2). The maximum length of the inter-
views will be 60 min. One independent researcher (first
author) will interview all participants. Interviews will be
audiotaped and typed out verbatim. The interviewer will
be blinded for measurement results to provide a neutral
attitude and prevent bias based on foreknowledge. Inter-
views will be held on the known FACT location or at the
patient’s home. Participants can stop the interview at
any moment. The audio files and written content of the
interview results are confidential.
Analysis
Quantitative analysis
Descriptive analysis will be used to describe the patient
characteristics and the repeated (outcome) measures. To
analyze the clinical outcomes of the NET, mixed models
will be used in a longitudinal analysis to estimate the
effect within the individual and the whole group, taking
into account the repeated measures.
Qualitative analysis
The qualitative data analysis forms a cyclic process, with
the interim analyzes modifying subsequent interviews.
This procedure is well known as the constant compara-
tive method. The texts of the interviews will be transcribed
literally and then entered in the ATLAS.ti computer
program for qualitative text analysis (Muhr & Friese,
2004). Then, they will be started with open coding: small
text fragments will be labeled. This label or code has
a descriptive nature and closely follows the text. At the
same time, questions and remarks about ambiguities in
the text or possible interpretations will be described in
brief notes. The next analysis stage will exist of joining the
small text fragments without losing the original codes and
labeling these fragments with a higher level of abstraction.
These codes will be not only descriptive but also
interpretative. During this process, the similarities and
differences between interviews will be explored according
to the principles of the constant comparative analysis.
During the third analysis stage, text fragments will
be further joined, categorized, and described. These
categories will reflect the dominant themes and possible
relevant determinants. The interviews will be indepen-
dently coded by two researchers.
Methodological objectivity
The methodological objectivity will be enhanced by (1)
purposive sampling confined to SMI patients who have
recently received NET treatment for comorbid PTSD, (2)
a neutral attitude in asking questions and in orally
checking the findings with the respondent, (3) researcher
triangulation: minimization of researcher bias by indepen-
dent coding and analyzing interviews by two researchers,
(4) member check in order to assess the accuracy of
the representation of the participant’s subjectivity, (5)
peer debriefing with the whole research group during
data collection and analysis, (6) peer debriefing with two
independent NET therapists and two FACT-team mem-
bers who care for the participants, (7) transparency and
reproducibility through careful documentation of all steps
of the research process. Interviews are tape recorded and
verbatim transcribed. The raw material is saved and stored
in its entirety to be available for verification purposes.
Integrated analysis
Integration of the quantitative and qualitative results
will be focused on interpreting how the qualitative results
enhance the understanding of the quantitative outcomes.
The quantitative and qualitative results of the experi-
enced symptoms (i.e., PTSD, dissociation, and present
primary disorder), perceived care needs, and quality of
life will be compared within each individual. Additional,
this will be analyzed at group level. Finally, congruent
and discrepant findings will be interpreted.
Ethics
The study will be conducted with ethical principles
that are consistent with the Declaration of Helsinki,
amended by the 59th WMA General Assembly, Seoul,
October 2008. The ethical approval for conducting the
‘‘NET for PTSD in SMI patients’’ study was provided by
the Committee on Research Involving Human Subjects,
Arnhem-Nijmegen (number 1843-2015).
Discussion
NET has been shown to be effective in vulnerable groups,
and first clinical results in SMI patients with comorbid
PTSD receiving FACT have been promising. To evaluate
and improve clinical practice, only relying on quantita-
tive measures might not suffice as it lacks sensitivity for
this specific population. Moreover, the mixed methods
approach further enriches the quantitative data with
qualitative interviews addressing patients’ perspectives
on effectiveness, barriers, and facilitating factors.
Registration
This study protocol is registered in The Netherlands
National Trial Register (NTR) with number NTR5714.
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